BLEPHAMIDE S.O.P. 0.2 %
PREDNISOLONE ACETATE : 0.2 % SULFACETAMIDE SODIUM : 10 % · DIN 00307246 · ALLERGAN INC
Health Canada status: CANCELLED POST MARKET
What is BLEPHAMIDE S.O.P.?
BLEPHAMIDE S.O.P. 0.2 % contains PREDNISOLONE ACETATE : 0.2 % SULFACETAMIDE SODIUM : 10 %. It is listed in the Health Canada Drug Product Database under DIN 00307246, held by ALLERGAN INC, supplied as OINTMENT for OPHTHALMIC administration. Health Canada currently lists it as cancelled post market, status dated 15-Jul-2019. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
What is BLEPHAMIDE S.O.P. used for?
Corticosteroid-responsive inflammatory conditions of the eye where bacterial infection or risk exists; chronic anterior uveitis; corneal injury from chemical, radiation, or thermal burns.
Authorized indication as written in the Health Canada product monograph. For healthcare professionals and licensed purchasers; this is not medical advice.
Product details and regulatory record
| DIN | 00307246 |
|---|---|
| Brand name | BLEPHAMIDE S.O.P. |
| Generic / active ingredient | PREDNISOLONE ACETATE : 0.2 % SULFACETAMIDE SODIUM : 10 % |
| Manufacturer | ALLERGAN INC |
| Strength | 0.2 % |
| Dosage form | OINTMENT |
| Route of administration | OPHTHALMIC |
| Schedule | Prescription |
| ATC code | S01CA02 PREDNISOLONE AND ANTIINFECTIVES |
| AHFS class | 52:04.08 ; 52:08.08 |
| Biosimilar | No |
| Health Canada status | CANCELLED POST MARKET |
| Status date | 15-Jul-2019 |
| Original market date | 1974-12-31 00:00:00 |
How is it administered?
Apply small amount to conjunctival sac 3-4 times daily and 1-2 times at night. Reduce dose gradually in chronic conditions; do not discontinue prematurely. Re-evaluate if no improvement after 2 days.
Included because it drives pack selection and wastage. Consult the monograph.
How is it stored and handled?
Store at 15° to 25°C. Protect from freezing and light. Store in an upright position. Discard if solution turns dark brown.
How is it supplied?
Sterile collapsible aluminum tube with ophthalmic delivery tip and polyethylene screw-cap closure.
Contraindications
Herpes simplex keratitis, vaccinia, varicella, viral diseases of cornea/conjunctiva; mycobacterial/fungal eye infections; hypersensitivity to sulfonamides, corticosteroids, or any component.
Warnings and precautions
May mask/enhance infection; extended use may increase IOP (glaucoma) or cause cataracts. Risk of Stevens-Johnson syndrome. May retard corneal healing. Do not use >10 days without supervision.
What can be used instead?
Other Canadian products sharing ATC code S01CA02 PREDNISOLONE AND ANTIINFECTIVES. 0 of 8 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| BLEPHAMIDE | 10 % | DROPS | ALLERGAN INC | CANCELLED POST MARKET | DIN 00807788 |
| DIOPTIMYD OINTMENT | 5 MG | OINTMENT | STERI-MED PHARMA INC. | APPROVED | DIN 02023784 |
| METIMYD OPH SUS | 5 MG | SUSPENSION | SCHERING-PLOUGH CANADA INC | CANCELLED POST MARKET | DIN 00177024 |
| ODAN-CIDE | 5 MG | SOLUTION | ODAN LABORATORIES LTD | DORMANT | DIN 00630640 |
| PREDNISOLONE/SULFACETAMIDE | 0.5 % | SUSPENSION | PHARMA STULLN INC. | DORMANT | DIN 02023814 |
| VASOCIDIN OPHTHALMIC SOLUTION | 100 MG | SOLUTION | NOVARTIS OPHTHALMICS NOVARTIS PHARMACEUTICALS (CANADA) INC | CANCELLED POST MARKET | DIN 02133342 |
| VASOCIDIN OPHTHALMIC SOLUTION | 2.5 MG | LIQUID | IOLAB PHARMACEUTICALS | CANCELLED POST MARKET | DIN 00843741 |
Who else supplies PREDNISOLONE AND ANTIINFECTIVES worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. PREDNISOLONE AND ANTIINFECTIVES appears in 190 registered pack listings across 10 markets, published on 9 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.